| Size & multiples | |||
| Market Cap | $888.5M | Enterprise Value | $1.21B |
| P/E (TTM) | 9.93× | PEG (trailing) | 1.88× |
| P/S | 1.23× | P/FCF | 6.57× |
| EV/EBITDA | 6.94× | EV/EBIT | 10.35× |
| EV/Sales | 1.68× | EV/FCF | 8.94× |
| FCF Yield | 15.22% | Buyback Yield | 10.59% |
| Owner Earnings (TTM) | $103.0M | Owner Earnings Yield | 11.59% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.87 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 8.37% |
| After-tax Cost of Debt | 3.34% | Synthetic credit rating | A- |
| Cost of Debt · embedded (pre-tax) | 4.21% | Cost of Debt · marginal (synthetic) | 4.89% |
| WACC | 6.32% | ROIC | 9.90% |
| EVA Spread (ROIC−WACC) | 3.57% | EVA | $40.3M |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $2.03 · revenue TTM $720.5M · FCF TTM $135.2M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E, EV/EBITDA
P/E 19th · EV/EBITDA 17th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 9.9x | 24.4x | 13.0x–39.3x | 19 ↓cheap |
| EV/EBITDA | 7.4x | 15.1x | 9.8x–24.4x | 17 ↓cheap |
| FCF Yield | 13.6% | -7.8% | -34.7%–1.4% | 96 ↑strong |
| Net Margin | 13.6% | -21.2% | -325.3%–7.2% | 84 ↑strong |
| Operating Margin | 19.5% | -34.5% | -552.0%–8.0% | 89 ↑strong |
